Indivior Finalizes Upsized $500M Convertible Notes Offering at 35% Premium, Repays Prior Debt

summarizeSummary

Indivior Pharmaceuticals, Inc. finalized its convertible senior notes offering, issuing $500 million in 0.625% notes due 2031, including the full exercise of an over-allotment option, and used proceeds to prepay an existing note purchase agreement.

check_boxKey Events

• Finalized $500M Convertible Notes Offering

  Indivior issued $500 million in 0.625% Convertible Senior Notes due 2031, including the full exercise of a $50 million over-allotment option. This follows the proposed $400 million offering announced on March 12, 2026, and the $450 million pricing announced on March 13, 2026.

• Premium Conversion Price

  The notes have an initial conversion price of approximately $41.66 per share, representing a 35% premium over the common stock's last reported sale price on March 12, 2026.

• Debt Repayment and Termination

  A portion of the proceeds from the offering was used to prepay all outstanding principal, accrued interest, and fees under a Note Purchase Agreement from November 2024, which has now been terminated.

• Potential Future Dilution

  Initially, a maximum of 16,202,200 shares of common stock may be issued upon conversion of the notes.

auto_awesomeAnalysis

This 8-K filing confirms the successful execution and final terms of Indivior's convertible senior notes offering, which was initially proposed at $400 million, then priced at $450 million, and ultimately issued at $500 million due to the full exercise of the $50 million over-allotment option. This upsize and full exercise indicate strong investor demand and confidence. The notes carry a low 0.625% interest rate and an initial conversion price of $41.66 per share, representing a significant 35% premium over the stock's price on March 12, 2026. A key use of the proceeds is the prepayment and termination of a prior note purchase agreement from November 2024, which strengthens the company's balance sheet by replacing existing debt. While convertible notes introduce potential future dilution if converted, the premium conversion price mitigates immediate concerns, and the successful capital raise provides substantial financial flexibility and runway.